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resumo 
 
 
Este trabalho apresenta uma experiência de estágio curricular com a duração 
de 9 meses, desenvolvido na ARC Publishing, uma empresa que opera nos 
ramos da comunicação e publicação científica. 
O estágio curricular foi orientado para a área da redação científica, no entanto, 
atividades em outras áreas, aqui designadas de atividade multidisciplinar, 
também foram executadas. A atividade multidisciplinar variou desde atividades 
relacionadas com o desenvolvimento de negócio e marketing até atividades 
relacionadas com a gestão editorial de revistas científicas. Já as atividades de 
redação científica incluíram a redação de artigos de investigação original, 
traduções de documentação relacionada com a investigação clínica, edição de 
livros e controlo de qualidade de outros tipos de documentação científica.  
Globalmente, este estágio curricular representou um ótimo complemento à 
minha formação académica. Tive a oportunidade de aprofundar o meu 
entendimento acerca dos processos envolvidos na produção e na 
comunicação de conhecimento médico/científico. Descobri novos tópicos de 
interesse. E, fiquei com uma visão mais ajustada daquilo que é a realidade do 
mercado de trabalho e das oportunidades disponíveis. Por fim, a junção destes 
fatores permitiu-me maturar as minhas perspetivas de desenvolvimento de 
carreia.         
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
keywords 
 
Curricular training, Internship, Pharmaceutical Medicine, ARC Publishing, 
Medical Writing, Medical Knowledge, Medical Research, Medical 
Communications, Medical Publishing, Editorial Management, Open Access 
Publishing. 
 
abstract 
 
The present work reports a 9-month curricular training experience developed at 
ARC Publishing, a company operating in the fields of medical communication 
and medical publishing. 
The training experience was oriented towards the medical writing field, but 
activities in other fields, here designated as multidisciplinary activity, were also 
conducted. Multidisciplinary activity ranged from business development and 
marketing, to editorial management. Whereas medical writing activities 
included preparation of original research reports, translation of clinical 
documents, book editing, and quality control of scientific documentation. 
Overall, this training period was an excellent complement to my academic 
education. I advanced my understanding of the processes involved in medical 
knowledge generation and communication. I discovered new topics of interest. 
And, I also improved my vision of the real marketplace and the opportunities it 
poses. Lastly, the combination of all these factors, allowed me to mature my 
perspectives for future career development. 
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 CHAPTER 1 - INTRODUCTION 
 
This document presents an overview of a curricular training period as a medical writer at 
ARC Publishing. This training period is encompassed in the Masters in Pharmaceutical 
Biomedicine (which is a part of the IMI PharmaTrain affiliated Training Programme in 
Pharmaceutical Medicine) by the University of Aveiro, Portugal. The master’s program is 
organised in manner that allows students to gain professional experience during the second 
year, through long-term curricular internships. 
This internship in particular, started in September 2012 and lasted up to May 2013. 
During this period I held the Associate Medical Writer position. However, the internship 
was also intended to provide me with a much broader perspective of the working 
environment, and thus I also executed several activities beyond the medical writing field. 
The main objectives for this internship were: 
- To apply the knowledge acquired during my academic education, particularly 
during the Masters in Pharmaceutical Biomedicine. 
- To get a better understanding of the working marketplace, particularly in medical 
research and communication. 
- To develop a broad range of activities, improving my soft skills and general 
working capabilities. 
- To develop my medical writing skills, complementing the learning from the 
masters’ program and achieving a fairly high level of expertise. 
To purse these objectives, the internship comprised diversified activities. The first 
three to four months were more heavily dedicated to multidisciplinary activity that went 
beyond the medical writing field. The remaining months were more heavily occupied with 
medical writing activity. However, this categorisation represents only a tendency; the types 
of tasks executed at different times were not strictly divided and many interlinks existed.     
To present this training experience I divide this document into four chapters. Here, on 
the first chapter, I present an overview of the state of the art for the fields in which ARC 
Publishing operates. Then, I describe the specific characteristics of ARC Publishing. The 
following two chapters contain a comprehensive description of activity developed during 
the training period. In chapter 2, I present the range of undertakings not directly associated 
with the medical writer position. Whereas in chapter 3, I describe the range of projects I 
was involved in as a medical writer. Finally, in chapter 4, I discuss the overall training 
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experience. I also conclude on the relevance of this curricular training for my academic 
and professional development. 
 
 
1.1. STATE OF THE ART 
 
Medical knowledge communication is a very comprehensive topic. In this section I 
overview the main activities and stakeholders. I start with a historical perspective on how 
medical knowledge has evolved over the years. Then, I present the main features of 
medical research and knowledge generation. Lastly, I present the main platforms used up 
until now to communicate medical knowledge, and also mention future trends in these 
fields.  
 
 
1.1.1. Medical knowledge evolution 
 
Since ancient times the way we approach health has greatly evolved. For many centuries 
we tried to tackle disease based on beliefs and religion. These strategies were not, 
however, particularly effective. As the centuries past, human ambition towards a better 
understanding of the world open the way to more reason-oriented lines of thought, 
progressively dooming religious endeavours to secondary roles [1]. 
The shift towards evidence-based medical interventions has its deepest roots in the 
Enlightenment period. This intellectual movement placed its emphasis on reason. As a 
result, the application of reasoning to all aspects of human life unravelled the great 
potential of science. In fact, scientific thought was increasingly adopted because it 
provided explanations based on evidence, which could actually be confirmed through 
experimentation. With increasing influence from science, health-related approaches also 
changed and the basic foundations of modern medicine were laid down [1]. 
Since then, medical knowledge evolved at great pace. Once thought reasonable 
explanations for health-related phenomena have been proved wrong and deeper—and 
hopefully more accurate—understandings of the mechanisms involved in health and 
disease have been established. The increasing success of biomedicine’s approaches to 
tackle disease was also accompanied by increasing social support. In fact, most societies 
across the globe today embrace biomedicine as their main strategy to address disease [1]. 
Particularly in the past few decades, medical knowledge boomed. New specialties 
arose, and for most cases we now have several levels of sub-specialties. In fact, some 
medical specialties today are almost knowledge universes in themselves. These 
developments were only possible with increasing support from all branches of society. But, 
perhaps even most importantly, these developments were possible because they were 
accompanied by developments in other—sometimes seen as unrelated—branches of 
science. Only with these developments, medical scientists—the origin of medical 
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knowledge—had access to the tools that allowed them to generate and massively distribute 
large quantities of information. 
Now, we reached the era of evidence-based medicine. Confirmation of theories by 
experimentation—as initially proposed by the Enlightenment ideas—is not enough. We 
actually need to study diverse sources and critically analyse the results to identify the best 
alternatives. This is where systematic reviews and meta-analysis assume their crucial role. 
By leveraging the information technologies available now, these studies combine evidence 
from different sources and apply sound statistical analysis techniques to provide us with 
unifying evidence on which strategies actually work better. This kind of research is 
increasingly adopted,  and in an environment of cost constraints it is reasonable to assume 
that in the future more and more of these studies will be conducted [2]. 
Unfortunately, these great advancements in modern medicine also pose great 
challenges for health professionals who need to keep up with the innovations. Medical 
knowledge is generated at great pace all around the globe by millions of researchers. 
Although, health professionals do not need to be up-to-date with every innovation, at least 
those innovations that might impact their professional practice they should be aware of. 
But, the problem is not only confined to truly disruptive innovations: medical knowledge is 
also target of constant renewal; what is accepted today may be updated or even discarded 
tomorrow. Therefore, this environment of constant change obliges health professionals to 
follow the evolution of medical knowledge (particularly in their fields of action) with great 
attention. 
Furthermore, this ever-growing rhythm of medical knowledge production does not 
show signs of reduction. On the contrary, with the increasing trend towards the “Big Data” 
age, more and more information related to human health will be produced. With 
personalised medicine we will be basically building knowledge on every patient—and if 
we think of health promotion on higher levels, we will probably be building knowledge on 
every citizen on a given community. Computational techniques, such as artificial 
intelligence or data mining, will also contribute to generate increasing amounts of health-
related information. In fact, these techniques may even contribute to actively generate 
signals, analyse hypothesis, and ultimately distil the overwhelming information that health 
professionals are confronted with [3, 4]. 
 
 
1.1.2. Medical research 
 
To build this wide and varied body of medical knowledge, diverse research players have 
historically looked to a variety of sources. Today most of modern medical research is 
perhaps based on well-structured sources, but is has not always been this way. In fact, we 
can divide the sources of medical knowledge into four wide categories, such as Figure 1 
illustrates [5]. 
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Figure 1. Historical sources of medical knowledge 
Adapted from: Chin R, Lee BY. Principles and Practice of Clinical Trial Medicine: Elsevier Science; 2008.  
 
Historically, we turned from occasional, less structured data sources to well-structured, 
aggregated data sources. Less structured data sources include anecdotal evidence (from 
clinicians’ experience) and case series. Since these sources do not oblige to rigorous study 
methodology (e.g. inclusion or exclusion criteria), they usually do not provide definitive 
conclusions. Nevertheless, they have played major roles in the evolution of modern 
medicine—even today these sources are being used, most medical journals still have case 
report and case series sections—passing down experience-based knowledge through 
generations of health professionals [5]. 
As for epidemiological studies and aggregate data from clinical trials the situation is 
different: these sources are well accepted as reliable and accurate. Epidemiological studies 
are somewhat in between anecdotal and aggregate data from clinical trials. Epidemiology 
uses formal collection and analysis methods, but there is not an active intervention, and 
therefore, epidemiological studies usually do not lead to causal inferences. On the contrary, 
aggregate clinical trial evidence is based on well-established methods (randomisation, 
control, etc.) to account for the sources of bias that afflict epidemiologic approaches. 
Clinical trials include active interventions, and thus they may lead to causal inferences [5]. 
All these sources are important to generate a strong and valid body of medical 
knowledge. Less structured sources are mainly used to generate hypothesis and provide 
preliminary information. Whereas epidemiology and clinical trial evidence is best suited to 
validate or discard these preliminary hypothesis. Independently of the data source used, it 
is of the most importance to assure the quality of the evidence. Less structured data sources 
should always follow good reporting practices. But, this is particularly crucial for 
methodological research. For the latter, several reporting guidelines are available: the most 
important are the STROBE guidelines for epidemiological studies and the CONSORT 
guidelines for clinical trials. And there is, of course, the good clinical practices as well as 
other applicable regulatory requirements that should always be followed [5]. 
In terms of research players, we see a huge variety of entities involved, but some 
trends are still identifiable. Basic medical research is usually undertaken by academic or 
Medical 
Knowledge 
Anecdotal 
evidence 
Case series Clinical Trials 
Epidemiological 
Studies 
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medical institutions. This research intends to establish the basis of healthy physiology as 
well as disease mechanisms. Normally, these undertakings are carried out with the 
objective of advancing medical knowledge and do not specifically focus on practical 
applications. This kind of medical research has been historically funded by public grants, 
privately held funds from the institutions themselves, or other non-profit organisations. 
Partnerships with private organisations are increasing, but they are still somewhat incipient 
at this point [5, 6]. 
Applied research—building on the information from basic research to provide health 
interventions—is typically more commercially attractive, and consequently, populated with 
private initiatives (mainly from pharmaceutical, medical devices, and other biotechnology  
industries). This trend is easily understandable since health-related interventions actually 
provide direct revenue, in contrast to basic research where most of the times researchers 
only “add value” to the body of medical knowledge [5, 6]. 
Development of health interventions (i.e. applied research) is typically aimed at 
producing interventions based on medicines (either chemical- or biological-based) or 
medical devices. Usually, a quite strict pathway is followed. Findings from basic research 
are thoroughly analysed to find the best targets to act on and, ultimately, obtain a desired 
outcome. Then, researchers speculate on which compounds are best suited to exert the 
intended action on the target. At this stage several compounds undergo extensive batteries 
of in silico and in vitro testing, so that only compounds with true potential for successful 
intervention are further developed. Then, animal testing takes place to mimic, at the best 
extent possible, the effects on humans; here toxicology testing is of extreme importance. 
Lastly, we have clinical trials (i.e. human testing) that test potential interventions in 
controlled environments with the main intent of ensuring that only safe and efficacious 
interventions are introduced [5, 6]. 
The clinical stage of drug development is typically divided into four phases. Despite 
some increasing trends for streamlining this development model, this is still the model in 
place for most drugs in clinical development today. Phase I studies usually enrol healthy 
subjects, intend to assess the safety of the compound under consideration, and provide 
useful insists on drug dosage for consequent studies. Phase II studies enrol patients (with 
the target disease), and intend to provide preliminary information on the safety and 
efficacy of the intervention for the target disease. Phase III studies (sometimes called 
pivotal studies) also enrol patients, but have much larger study populations (sometimes 
several thousands); these studies intend to establish the safety and efficacy profiles of the 
intervention and compare these characteristics with those of the existent standard 
interventions. Phase IV studies are conducted after the medicine is approved and in use by 
the general population; given that these studies include “real-life” patients, they intend to 
provide evidence of the actual benefits and risks for the intervention. Figure 2 depicts the 
characteristics and relationships of each drug development stage [5, 7]. 
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Figure 2. Drug development phases 
Source: Chin R, Lee BY. Principles and Practice of Clinical Trial Medicine: Elsevier Science; 2008. 
 
Developing medical devices is quite different from developing medicines. Although 
medical devices are around for quite some time, regulatory requirements for these kinds of 
interventions are usually not so tight. Medical devices are developed with a scientific 
rationale similar to that applied in drug development: a target for intervention is selected, a 
form of intervention is designed (i.e. a medical device), and the device is consecutively 
tested to ensure safety and effectiveness. The main difference is the fact that here the 
amount of testing highly depends on the device’s characteristics, particularly on the risks it 
poses. Low risk devices may only have to be registered with the competent authorities, 
while high risk devices may need to undergo extensive animal and clinical testing [8, 9]. 
Independently of the types of interventions under study, applied research is always 
associated with stricter regulatory requirements. This is particularly true for studies 
involving interventions on human subjects—clinical trials. Regulatory requirements 
improved overtime in an attempt to ensure safety and effectiveness of medical 
interventions available. Nowadays, most—if not all—developed countries have competent 
authorities to evaluate medicines and medical devices. In the European Union for instance, 
there are centralised (European Medicines Agency) and decentralised authorities (member 
state’s specific authorities). And despite the wide range of competent authorities around 
the world, we have today a worldwide organisation—the International Conference on 
Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human 
Use (ICH)—that has actually harmonised (to the extent possible) the requirements for 
developing medicines. These endeavours have facilitated the development process, mainly 
through the use of harmonised guidelines, but there are still some challenging regulatory 
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hurdles that drug developers need to overcome in order to successfully commercialise their 
products. 
But, these regulatory hurdles also represent an opportunity for clinical research 
organisations (CRO) providing specially conceived, highly effective services. This is true 
for the full-service CROs market that emerged in the last decades, but also for the niche 
CROs, which have the capacity to provide specialised, high-quality services. The medical 
writing niche CROs, are particularly favoured with the increasing regulatory requirements, 
since well-developed documentation is crucial to meet them. These CROs have particularly 
good business opportunities in developing top-quality study protocols and study reports, 
but also other types of scientific documentation required by competent authorities for 
marketing authorisation applications. 
While this whole model of medical knowledge generation has been in place for 
decades, the new circumstances that have arisen in the past decade will lead most players 
to rethink their strategies and refocus their efforts. This change is particularly important for 
the applied research sector. Here, productivity (number of new medicines marketed) has 
been declining despite the growing costs. Pharmaceutical industries faced with this 
scenario will probably reshape their development model in order to share the increasing 
risks with other entities. This includes partnering with academia, leaving the early steps of 
applied research for properly equipped academic centres. But, also includes embarking in 
larger public-private enterprises to develop cost-effective solutions [10]. 
In the information era, the development model itself will tend to become more flexible. 
The concept of developing medicines for large a population—associated with potential 
high profits—is almost over, and tailored solutions will emerge as we walk towards a 
personalised medicine paradigm. Very strict clinical development phases—where most 
development costs come from—will probably fade and more efficient processes will 
emerge. This may include in-life testing models where aggregate clinical data but also 
simulated data sources will be jointly used to safely introduce therapies in patient 
populations or indications for which they have been proven adequate. These flexible 
approaches will make therapies readily available for patients, but will also reduce the 
impact of high upfront development investments, and most importantly, the high costs of 
failure [11-14]. 
Of course, to successfully transform this historically so complex knowledge generation 
model, good communication will be crucial. Players involved in developing and 
commercialising health innovation (medicines, devices, etc.) have historically bet on 
marketing-based communication strategies, but there is an increasing demand for more 
scientific-based, balanced, and accurate communication. With the increasing trend for 
flexibility in the development model, access to balanced and trustworthy information will 
also be increasingly valued by health professionals. This represents a good business 
opportunity for entities specialised in communicating science, which will make the bridge 
between scientific information hunger health professionals and marketing oriented 
pharmaceutical or medical devices industries. 
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1.1.3. Communicating medical knowledge 
 
Throughout the years, medical knowledge has been communicated by a variety of 
methods. We can divide these methods into a personal communication level or a broad 
communication level. Personal communication includes experience-based teaching and 
other person to person communication forms where health professionals exchange 
experiences to increase their knowledge. Communicating medicine on a personal level was 
particularly crucial during the early stages of modern medicine, centuries ago. Back then, 
most professionals did not have access to more elaborated communication forms, and 
advancements in their practices were highly dependent on exchanging personal 
experiences. Nevertheless, this kind of medical communication continued to play 
significant roles, and even today health professionals look up to their peers for information, 
despite the increasing information sources available. 
Broad communication platforms include health professionals’ organisations, scientific 
meetings, and medical journals. Organisations of health professionals are intrinsically an 
extension of the personal communication paradigm. Health professionals associated with 
these organisations have communication with their peers facilitated; these organisations 
also provide a way to keep up with their professional fields of interest. Scientific meetings 
also provide direct personal contact with professional peers. Those kinds of meetings 
facilitate a more formal approach to medical communication, which sometimes include 
oral communications or poster presentations to potentially wide audiences. Historically, 
scientific meetings have actually historically been one of the major ways of 
communicating medical knowledge. In this age of increasing specialisation in medicine, 
scientific meetings tend to retain their place in medical knowledge communication as more 
specialised meetings are held [15]. 
Finally, at a much broader communication level we have the medical literature. The 
first general medical journals were originally published towards the end of the 18
th
 century, 
and sometimes these journals were an extension to scientific meetings. As the time past, 
more specialised journals began to arise, and already during the 20
th
 century even sub-
specialty journals were already available. Medical journals assumed increasing importance 
and portrayed themselves as very powerful tools for medical knowledge communication, 
and most importantly, knowledge dissemination to an ever growing variety of audiences. 
Besides their major role of knowledge communication, medical journals also constituted 
important forums for medical discussions, entertained their readers, and even proved 
effective tools for certain types of campaigns [15]. 
Of course, these different communication forms are associated with different relative 
importance. Communicating on a person to person basis with professional peers has a very 
small potential to influence medical practices at a universal level. As for communications 
at broader level, intervening at scientific meetings is somewhere in the middle of this 
potential impact scale. Here, fairly large numbers of professionals might be gathered, so 
fairly large numbers of medical practices might be affected. Additionally, communications 
held at scientific meetings are sometimes published in the medical literature, which allows 
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further dissemination. Nonetheless, publications on medical journals—particularly peer-
reviewed journals—are generally seen as more relevant contributions to the body of 
medical knowledge. This is justified by the incomparably larger audiences reached by 
medical journals and the potential impact of those in actual medical practices. However, all 
of these publication forms remain suitable approaches for different types of 
communications; the key is to properly match the relative importance of the 
communication form with the relevance of the communication content. 
Medical journals are not all the same. We have peer-reviewed broad-based journals, 
which publish on most medical topics. Examples of this class are the New England Journal 
of Medicine or The Lancet. These types of journals tend to be well known among a wide 
variety of health professionals; they have very large audiences, and at least for the most 
reputed ones, they are seen as the go-to journals for really ground-breaking research 
reports. Then we have peer-reviewed specialty journals, which only publish on a specific 
area of medicine. These journals are sometimes associated with organisations of health 
professionals for a particular specialty. Although they do not guarantee the kind of 
exposure broad-based journals do, they can be important when the authors are particularly 
interested in being read by professionals in a given specialty. These days, specialty 
journals have reached the sub-specialty level, and in extreme cases even the sub-sub-
specialty level was reached. Lastly, we also have controlled circulation journals. These 
journals usually aim to provide practical information for clinicians. They may contain large 
quantities of articles reviewing the medical literature, summaries of research reports, and 
practical guides for health professionals. Even here, there also journals specialised in 
diverse areas of medical knowledge [16]. 
Medical journals publish diverse contents. Table 1 summarises the types of articles 
most broadly published among journals. Given the singular characteristics of each type of 
article, they are usually regarded with different relative importance. This classification is 
based on criteria such as the work involved in producing the paper, the scientific relevance 
of the paper, the validity of the methods employed, etc. Original research reports, meta-
analysis and systematic reviews (which in a way also constitute a research article) are 
regarded as the most important journal publications. Letters to the editor, editorials, and 
case reports are normally regarded as less important publications, which is comprehensible 
in the sense that these publications are much more simple (and easy to prepare), may 
represent personal opinions, and do not rely on a very strict scientific methodology. This 
categorisation of articles is, of course, not so straightforward, because a wide variety of 
factors can affect the importance of journal articles. Nevertheless, this evaluation plays 
important roles in career development as well as attribution of grants. But, despite the 
different levels of importance for journal articles, authors should still keep in mind that 
different types of articles meet different communication needs, thus they should wisely 
select the types of articles they will write [16]. 
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Table 1. Types of articles published in medical journals. 
 
Type of article Characteristics 
Original research report Reports findings from carefully designed scientific experiments. 
The article usually follows a strict structure: Introduction, Methods, 
Results, and Discussion.     
Traditional review article Presents an overview of a specific medical topic. The article is 
designed to present what is known about the topic, but a strict 
research methodology is not employed. This type of article usually 
does not add new facts to the literature.  
Literature review Presents the state of the art. Literature reviews summarise the 
knowledge in a given topic taking into consideration large 
quantities of articles. This kind of article is usually written by 
experts in the topic at hand. 
Systematic review/meta-
analysis 
Reports scientific investigations that analyse data from previously 
published studies. A careful research methodology is 
implemented to select the studies analysed. A qualitative 
systematic review only summarises the studies, whereas a 
quantitative systematic review (also called meta-analysis) actually 
combines the data using specially designed statistical methods. 
Case report Presents a single (or small number) of interesting clinical cases. 
Case reports focus on unusual disease manifestations, 
therapeutic outcomes, or combinations of other unusual clinical 
presentations.    
Editorial Greatly varies in terms of contents. Usually editorials are written 
by the journal editors or an invited expert. Editorials reflect the 
author’s personal opinion on the subject at hand. In some cases, 
the editorial is merely a comment on the contents of the journal 
issue. 
Letter to the editor Provides a platform for readers to discuss aspects from previous 
editions. Letters to the editor allow readers to express concerns, 
present new perspectives, and even share knowledge from their 
experience that did not qualify for a “regular article”.  
 
 
The peer-review process is defined by the International Committee of Medical Journal 
Editors (ICMJE) as: “the critical assessment of manuscripts submitted to journals by 
experts who are not part of the editorial staff.” This is the preferred method to guarantee 
quality in the medical literature: it is designed to prevent erroneous materials from being 
published and help authors improve the overall quality of their papers. But, the peer review 
process is not a perfect quality assurance tool. In fact, several studies have demonstrated 
serious faults associated with the process: it’s inefficient, often biased and arbitrary, and 
not very good at detecting errors or fraud. Nonetheless, at this time the expression “peer-
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reviewed journal” still carries a lot of importance among the community and alternative 
procedures have not yet proved effective enough to be seen as credible go-to alternatives 
[15, 17-19]. 
To assess the quality of publications on medical journals, other tools besides 
employing the peer-review process are used. One of the most widely used is the journal 
impact factor (JIF), which provides a rough estimation of the journal’s relevance and 
prestige based on the number of times the articles on the journal are cited. The JIF was 
invented in the 60’s, based on Thomson Reuters (by then known as Institute of Scientific 
Information) scientific articles indexing tools. A JIF provides a 2-year average of the 
number of citations each article in the journal receives. Figure 3 illustrates the formulae 
used to calculate the impact factor.  
 
 
                    
     cites t  articles  u lis e  i           
 u  er    articles  u lis e  i           
 
 
Figure 3. Impact factor formulae 
 
 
Despite the increasing concerns associated with the JIF (even some notes from Thompson 
Reuters itself about using the JIF with caution), it remains widely used for a variety of 
purposes: guiding authors in selecting journals, assisting publishers in market research 
activities, and even helping assess merits for academic career development and grant 
attribution [20]. 
Beyond the JIF, the number of citations itself can also be a useful indicator of quality. 
High numbers of citations generally indicate scientific relevant publications, which are 
useful for other authors when preparing their papers. But, the number of citations should 
also be used with caution: articles might be highly cited because they contain serious 
errors. Other methods have been proposed to evaluate journals, individual articles, or even 
authors. Table 2 provides an overview of the most widely disseminated alternative 
methods to assess quality in the medical literature. Despite the merits of these alternatives, 
the JIF and the number of citations continue to be highly regarded in the community. 
Independently of the measures used, when assessing the quality of items in the medical 
literature, we should be cautions, since the several methods proposed and in use today 
present faults and there is not an undeniably fail proof approach [20, 21]. 
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Table 2. Alternative measures of journal impact 
 
Measure Description 
Eigenfactor Provides an estimate of impact on a given year, based on the number of 
citations in the Web of Knowledge database. Citations from highly cited 
journals weigh more than those from less-cited ones. This measure 
considers a 5-year timeframe and does not include self-citations [22, 23]. 
Article Influence Is derived from the Eigenfactor and provides an estimate of the average 
influence of articles during de first 5 years after publication [22]. This 
measure is normalised to allow easy interpretation (i.e. values above 1 
indicate higher influence while values bellow 1 indicate lower influence).  
Immediacy Index Estimates the frequency in which articles are cited in the year of publication. 
The Web of Knowledge database is used [22]. 
Cited Half-Life Indicates the median age of the articles cited on a given year on the Web of 
Knowledge database, reflecting for how long articles continue to have 
impact on the scientific community [22]. 
SCImago Journal 
Rank 
Provides an estimation of the journal impact based on citations from a 3-
year timeframe. Citations from high impact journals weight more in the 
calculation. Self-citations are ignored and all articles in the journal are 
c  si ere  (i.e. “cita le” a   “   -citable” ite s). This measure is based on 
the Scopus database, which more comprehensive than the Web of 
Knowledge, especially for new and non-English journals [22]. 
h-index Reflects the number of articles (h) that is cited at least h times. This 
measure was originally designed to assess both impact and productivity of 
individual scientists, but now it is also used to assess journals and even 
countries. The h-index can be calculated from a variety of databases and 
re er t  s eci ic ti e  eri  s    ti es (e.g. G  gle Sc  lars’  etrics  age 
provides 5-year h-index for indexed journals). The calculation is not 
normalised to the number of articles published, favouring high numbers of 
publications [22, 24, 25]. 
 
 
The number of medical journals available worldwide boomed as modern medicine entered 
the information era. This fact is easily illustrated by searching the literature for articles on 
“How to keep up with the medical literature”. In 1954, Flaxman published such an article, 
in which he stated: “One of the commonest complaints of physicians is their practicing 
difficulty in keeping up with medical literature. With some 400 medical journals in the 
English language alone listed in the Quarterly Cumulative Index Medicus, this literary 
ailment seems almost entirely justifiable” [26]. He describes some practical tips for health 
professionals to search periodicals for possibly relevant information for their practice. In 
1986, Haynes et al already mentioned: “Access to the medical literature through personal 
computers is now readily available and can greatly reduce logistical barriers to using 
recently published journal articles to support clinical decisions”[27]. Here, the authors 
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already described an advanced computerised search method, which reflects the change in 
the way health professionals interact with the medical literature due to the overwhelming 
increasing number of publications. Today, PubMed indexes more than 22 million articles 
in life sciences and biomedical topics. And, the rhythm of indexed content continues to 
increase every year (at rates higher than 500,000 articles per year) [28]. 
This crowded publication environment not only represents increased difficulties to 
professionals searching through the literature for relevant scientific data, but also makes it 
very difficult for authors to get their ideas and results out there with the desired impact. 
This is particularly critical for academicians trying to build a solid career, since in 
academia the “publish or perish paradigm” prevails. Thus, it is very important to stand out 
from the crowd when health professionals publish their work in the medical literature. This 
represents a huge business opportunity for organisations providing highly effective medical 
writing and data presentation services. Often, health professionals do not have the technical 
capabilities to prepare exquisite reports, and partnering with professionals in this area can 
really add value to the final product and help ensuring that the impact of the publication is 
properly maximised. 
Still, the revolution in the way medical knowledge is communicated is far from being 
complete. The advent of the internet brings up exciting new possibilities. Today, the 
internet already reaches the most inhospitable places and continues to be extended every 
day. This constitutes an amazing platform to extend the potential audience for many 
medical publications. Besides, digital content transmission also provides interactive 
capabilities, which have the potential to facilitate communication at both ends of 
knowledge transmission. Even new ways of communicating medicine may arise based on 
advanced social media platforms already available. And all of this is at a very low cost, in 
fact, with the increasing adoption of cloud computing solutions, more effective resource 
usage can be attained, leading to reduced costs and eventually reaching residual costs when 
compared with the potential gains [29-31]. 
 
 
1.1.3.1. Movement towards Open Access publishing 
Traditionally, medical journals were funded by subscriptions, which were mostly acquired 
by institutional libraries, but also individual researchers. In this model, the authors 
provided the contents to publish—along with the copyrights over the contents—and the 
reader (or the libraries of their institutions) paid a subscription to access the journal (more 
recently, readers could also pay a given fee to access just a specific article). Revenue from 
subscriptions was sufficient to cover expenses with the peer-review, editorial, and 
publishing process. Given that most journals were paper-based, articles took variable times 
from submission to print, but usually several months were required. However, as the 
Internet became more widely available, there was an increasing trend to make contents 
freely available on-line. In this context, open access (OA) publishing promised to give 
authors wider audiences and faster publication times, since contents were readily available 
online. 
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In fact, the medical publishing industry has seen an increasing trend towards open 
access publishing in the past decade. The Public Library of Science (PLOS) (one of the 
pioneers in OA publishing) defines OA as “free immediate access to, and unrestricted 
reuse of, original works of all types”. This definition admits that open access materials 
besides being readily and freely available, do not contain restrictions of use, including the 
ability to create derivative works or even make commercial use of published materials. 
However, that is not always the case for all publications broadly defined as OA. 
Particularly, for publishers previously in the business of restricted access publishing, some 
restrictions may apply to materials denominated as “OA”. Given this diversity in the terms 
in of use, several OA models were implemented over the years. Table 3 describes the main 
models in place [32, 33]. 
 
 
Table 3. Open Access models [30, 34]. 
 
Open Access Model Characteristics 
Gold Open Access Materials are immediately freely accessible online. All articles in the 
journal are freely accessible. Authors may be required to pay a 
publication fee to support the editorial and publishing processes.   
Hybrid Open Access Some articles are immediately freely accessible online in an otherwise 
restricted access journal. Authors are usually require  t   ay a  “  e  
access  ee” t   verc  e t e   te tial l ss i  reve ue  r   su scri ti  s 
and pay-per-view fees. 
Green Open Access Authors publish the final article on a personal, institutional, or central 
repository. Depending on the agreements with the journal, the article 
 ay   ly  e  reely availa le a ter a  “e  arg   eri  ”  esig e  t  
minimise revenue losses to the publisher. 
 
 
The main advantage associated with OA publishing is the wider audience these journals 
provide: since articles are available on the web for free, virtually anyone can read them. 
Providing an unrestricted audience means a great deal in this environment, because authors 
write to have impact on the development of medicine and not to receive royalties derived 
from potential sales. In fact, studies show that OA access articles have more full-text 
downloads when compared with similar restricted access articles. Thus, OA actually 
ensures dissemination of the work [35, 36]. 
The increased exposure associated with OA publishing is sometimes also identified as 
a chance to increase the number of citations and consequently the JIF. But, studies have yet 
failed to demonstrate this advantage. Several factors can affect this trend, one of which is 
the reputation of long established restricted journals vs. newly established OA journals, 
which leads authors to publish their best study reports on more prestigious restricted 
journals, affecting the citation rates [32, 35]. 
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Another advantage is the existence of fewer—if any—copyright restrictions. OA 
journals usually allow authors to retain the copyrights. This facilitates the use of the 
contents in future works, and allows the authors and even other parties to make derivative 
works  without having to ask for permissions (which most of the times have to be paid for) 
[30]. 
Additionally, over the last few years public funding institutions issued policies stating 
that results from public-funded research must be made available to the public. These 
policies were introduced because there was a general understanding that in many instances 
public institutions—and ultimately the taxpayers—were paying to produce knowledge and 
then paying again to access it. For instance the American National Institutes of Health 
issued this policy in 2008, requiring that all peer-reviewed journal articles were submitted 
to a central repository (PubMed Central) and made publicly available after acceptance. 
Similar rules are also already in place in the European Union and continue to be 
implemented worldwide [32, 37]. 
One of the main arguments against OA publishing is that OA journals tend to have 
lower quality than traditional ones. The peer-review system of these journals is sometimes 
seen as too quick, with articles not properly scrutinised. But, over the years this argument 
has been refuted by the emergence of high quality peer-reviewed OA journals. These 
developments led to a general understanding that, if well prepared, OA publications can 
reach the same level of quality than traditional, well-established, restricted access ones [30, 
37]. 
Another problem usually pointed to OA journals is the possible transfer of costs from 
the readers to the authors. Publishing an article has associated costs, even when journals 
are “online-only”. These costs depend on a variety of factors (e.g. the rejection rate for the 
journal), but recent estimates point to costs of at least $2,000-2,500 per article in online 
only OA journals [31]. OA tend to charge authors a publication fee, which in many 
instances may represent another hurdle for authors with limited research funds—think for 
instance of authors with limited budget and negative results, will they pay to publish? But, 
the costs of publishing in OA journals are also reason for concern in highly active research 
institutions. Several studies already demonstrate that the major players in academic 
research worldwide will actually pay more to make their articles OA, than they would pay 
to continue in the traditional model of subscribing journals for their libraries. For instance 
Cornell University would have to spend an additional 1.5 million USD if switching to OA 
publishing, while Harvard Medical School—with its 10000 articles per year—would 
require an additional 9.75 million USD to fully switch to OA publishing [30, 31]. 
During the past decade, several strong OA publishers have emerged. PLOS is perhaps 
the most well-known case. PLOS published its first journal in 2006: PLOS ONE. During 
2006 they published 138 articles. Impressively, only 5 years later that same journal 
published 13,798 articles, corresponding to 1 in 60 articles indexed to PubMed that year.  
The same trend is visible in other journals also published by PLOS. The same success story 
happened with BiomedCentral. This OA publisher was funded by venture capital in 2000 
and due to its success was later acquired by Springer—the biggest publisher in the 
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biomedical area. Contrary to allegations of lack of financial sustainability for OA 
publishing, these examples prove that well-designed OA business models might actually 
work. In fact, today many other important players exist, including Hindawi, Dove Press, or 
Medknow. Also, traditional publishers such as Sage or Nature groups are increasing their 
OA portfolios [30, 32]. 
This growth in OA publishing is also demonstrated by specific studies assessing the 
proportions of OA articles published throughout the years. Laakso et al [38] found that 
from 2000 to 2009 OA publishing grown at remarkable rates: 18% more journals and 30% 
more articles per year. In 2011 Laakso et al [39] also found 340,130 articles published in 
OA journals, which accounted for 17% of all articles published. While, this figures group 
all fields of science, medical publishing may even present an higher OA publishing rate: 
Bjork et al [40] already estimated that, in 2009, 13,9% of medical articles were published 
in Gold OA and 7,8% were published in Green OA, which only by itself already accounts 
for 21,7%—already higher that the general estimates for 2011. 
Thus, OA publishing appears to be at least an important trend in the future of medical 
(and generally all scientific) publishing. Estimates point that this growth in market share is 
to be continued in the coming years, and by 2019 OA publishing will represent 60% of the 
market [30]. Nonetheless, traditional restricted access journals will co-exist with OA ones 
for a long time—after all who will turn down a possible publication on Nature for a 
publication on an OA journal? Traditional journals still enjoy—and probably will for some 
time—valuable reputations gained over the years. This provides a reward for authors that 
when publishing scientific articles tend to value reputation and impact over openness and 
availability. Therefore, there is a clear trend for medical journals to move towards OA, but 
restricted access journals will still have their place, particularly the more reputed ones. 
 
 
1.2. ARC PUBLISHING 
 
ARC Publishing is a Portuguese start-up company acting in the areas of medical 
communication and medical publishing. Medical communication agencies are companies 
specialised in providing communication services to most players in the medical research 
area, but particularly to the pharmaceutical industry from which most centralised 
investments (i.e. single projects with large budgets) come from. Medical communication 
agencies address a wide range of communication platforms: legal and regulatory 
documents, scientific publications, poster presentations, medical education materials, and 
even promotional materials. Some go even further, and provide market research or public 
research services. Some agencies provide a wide range of these services, but perhaps most 
medical communication agencies focus on a particular area [41]. 
Medical publishers provide publishing platforms for players in the medical research 
arena. Traditionally, medical journals and books were the more widely used platforms. 
This business area has presented continued growth for decades, and was even thought 
“recession proof” up until recently. Nowadays, new paradigms threaten the business 
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models traditionally used. The challenges brought by the digital era are still to be 
overcome by most publishers, but two main trends at medium- to long-term can be 
identified: the growth in digital publishing and OA. Digital publishing presents particular 
challenges for book publishing undertakings due to the lack of efficient legal protection to 
ensure financial sustainability. OA assumes particular relevance for medical journals, with 
potential to take a dominant market position within this decade (see section 1.1.3.1). For 
both these issues, medical publishers continue to look for the right business model, but 
there are already indications that digital and OA publishing will play major roles, and 
therefore they represent good business opportunities for companies trying to establish 
themselves in the business and gain market relevance [30]. 
ARC Publishing takes advantage of these business opportunities in medical 
communication and medical publishing. ARC Publishing aims to deliver high quality 
services in both of these areas, tailored to the Portuguese reality, but also aiming for 
international exposure, particularly for the publishing services. These services are 
particularly centred in the medical education business of medical communication agencies 
(i.e. medical writing for scientific publications), and in the OA journals as well as book 
publishing services of medical publishers. 
 
 
1.2.1. Mission 
 
ARC Publishing’s mission statement is as follows: 
“The ARC Publishing mission is to provide superior medical writing, statistics and 
publication services, helping you to get out the most of your work, to enhance your 
reputation among peers, and transfer to society the best of your knowledge.” 
This mission reflects the two threads of ARC Publishing’s operations. In fact, at ARC 
Publishing’s website homepage, this mission is even identified as a double mission, 
comprising the following parts: 
- To provide superior medical writing, statistics and training services, allowing you 
to comply with the highest clinical research quality standards and to get the most 
of your data. 
- To promote the sharing of scientific knowledge through any form of publication. 
 
 
1.2.2. Services provided 
 
The range of services provided by ARC Publishing can be can be categorised as follows: 
Medical Writing, Statistics, Publishing, and Training. 
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1.2.2.1. Medical Writing 
Medical writing services are tailored for two kinds of clinical research players: individual 
clinician or small groups of clinicians, and large organisations (e.g. pharmaceutical 
industry). 
Medical writing for clinicians comprises two different kinds of projects: 
Report/publication preparation – writing service aimed at assisting clinicians with 
limited resources (e.g. time, writing expertise, etc.). This service comprises the most 
diverse publication forms: journal articles, poster presentations, oral communications, or 
abstracts for medical conferences. Additionally, the service also includes revision and 
editing of other types of scientific documentation, such as book chapters, academic thesis, 
etc. 
Clinical research support – integrated solution to assist in the implementation and 
execution clinical research activities. This service is well beyond the medical writing field 
as it provides support throughout the entire clinical research process, but since most tasks 
actually consist of preparation of writing documentation, it is included here for 
conceptualisation purposes. Support to clinicians includes preparation of the study protocol 
and related documentation, assistance in database development, statistical analysis, and 
report writing.  
In terms of medical writing for large organisations, services range from translation of 
clinical research documentation to writing online informative contents. As with individual 
clinicians, preparation of scientific publications is also available (for all publication forms 
previously described), but large organisations have also available editing and publishing 
services for conference proceedings or even medical journals. 
 
 
1.2.2.2. Statistics 
Statistical consultancy services provide clinical research players with validated and cost-
efficient support for their studies. Statistical consultancy can be used at most phases of 
clinical research projects, but early assistance is advised. These services add value to the 
research project by providing statistically sound techniques for clinically well-developed 
studies. 
 
 
1.2.2.3. Publishing 
Publishing services provide easy access to high quality publishing platforms. These 
services include the most varied types of scientific publication forms. ARC Publishing is a 
valuable option for publishing periodical medical journals, but also books, book series, and 
conference proceedings. The publishing services are specifically designed to ensure the 
quality of the publications, as well as to maximise their scientific impact. 
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1.2.2.4. Training 
ARC Publishing makes available several types of training sessions on the areas of 
expertise of the company. Training topics include Medical writing and scientific 
communication as well as biostatistics. Training sessions are tailored to the audience’s 
specific needs in order to provide attendees with easily applicable knowledge. 
 
 
1.2.3. Working environment 
 
ARC Publishing is a small enterprise with home-based associates. Given the nature of 
services provided, the company takes advantage of the new communication channels made 
available by information technologies, so all associates remain home-based. In-person 
meetings are held as required, depending on the projects under development. Therefore, 
the activities described in the following chapters of this report were developed under these 
circumstances. 
 CHAPTER 2 – MULTIDISCIPLINARY ACTIVITY 
 
One of the advantages of working for a start-up company is the chance to participate in a 
wide range of activities. As such, during this internship at ARC Publishing, I enjoyed the 
opportunity to develop varied multidisciplinary tasks. This gave me the chance to gain 
general working experience. 
In this chapter, I group the main multidisciplinary activities into four broad categories: 
business development and marketing, information technologies, quality assurance, and 
editorial management. Nevertheless, this is not rigid structure: several interlinks between 
those categories are present. 
 
 
2.1. BUSINESS DEVELOPMENT AND MARKETING 
 
Developing a successful company requires sound business development strategies. 
Business development includes a wide range of activities that aim to take advantage of 
potential growth opportunities. These activities range from traditional management tasks to 
marketing strategies and even sales. 
During my internship I got to know the company’s business strategies. I also 
implemented some activities to achieve the business goals defined. In the following 
sections, I describe particular tasks carried out in this area. 
 
 
2.1.1. Website content preparation and translation 
 
One of my first tasks when I arrived at ARC Publishing was accompanying the 
development of the contents for ARC Publishing’s website, and then translating them from 
English to Portuguese.  
Developing website contents is a very challenging task. The contents should be 
adequate for the broad audience that might access the website, but at the same time 
sufficiently directed for particular stakeholders (i.e. the prospective clients). The website is 
the image of the company, and therefore it is crucial that the messages are carefully 
crafted: readers actually capture the core values, missions, processes, and added-value the 
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company represents. For a medical communications company the website assumes an even 
greater importance, since it is in some way a reflection of the company’s capacities in 
getting the right messages through.  
To achieve this level of refinement, the contents went through several iterations of 
conceptualising, writing, and revising until the text was considered ready for publication. 
Accompanying this process made me understand that in the marketplace, relatively simple 
and not often though of tasks might represent great challenges. Thus, they should be well-
planned and not underestimated. 
At the company English is considered the main language, since this is the language in 
which most scientific knowledge is transmitted worldwide. Thus, documentation is initially 
prepared in English and then translated as required. In this case, since the website is 
available in English and Portuguese, I translated the contents to Portuguese.  
Despite Portuguese being my native language, this was not as straightforward as it may 
look. Good translations ensure that the meaning remains intact. But, maintaining the 
meaning is challenging, particularly when idiomatic expressions are used in the original. I 
have also encountered additional challenges associated with translating personal pronouns, 
because in Portuguese these words are applied in a substantially different manner.  
Therefore, translating the contents to Portuguese presented me with some unexpected 
challenges. But it also allowed me to gain experience in dealing with these issues and 
develop strategies to tackle them in future projects. 
 
 
2.1.2. Development of electronic newsletters 
 
Most marketing strategies today try to improve online presence, and electronic newsletters 
help achieving this goal. My work in this area was analysing the best technical tools to 
implement ARC Publishing’s marketing strategy. 
Developing electronic newsletters requires extensive work. To be successful, we have 
to make sure the right message reaches the right audience. Additionally, newsletters have 
to stand out, since internet users receive dozens, if not hundreds of these messages per 
month. Users are likely to spend only a few seconds on each newsletter—that is if they 
even open it at all—so it is crucial to insert visually appealing elements in addition to the 
targeted text to gain their attention and make sure they keep reading. 
Besides targeting the message, technically building the newsletter is also a defiant task. 
Electronic newsletters are usually written in HyperText Markup Language (HTML) 
(traditionally the most widely used programing language on websites) and then sent over 
email. Nevertheless, programing these emails is a tricky task, since most email clients (the 
software in which internet users read their email) are very selective in terms of the 
technologies associated with HTML they support. For most of them the programmer can 
only use the HTML technologies existent in the 90’s. Even though some clients support 
more advanced technologies, newsletters have to be built in a manner that ensures they are 
supported by all email clients, so that the message correctly reaches all addressees. 
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To carry out this task I considered the specifics of this kind of communication and also 
the technical difficulties involved. I came across several solutions, including the use of 
specialised software and web services. Eventually, I settle on a strategy for electronic 
newsletter preparation and sending. This knowledge was later applied as part of a 
communication strategy (see section 2.4.1.2). 
 
 
2.1.3. Development of contacts databases 
 
To successfully implement a communication and marketing strategy, gathering the right 
contacts is also vital. My work here consisted of defining the format for a database of 
contacts, followed by a process of narrowly gathering contacts.  
During this task I had to try different types of database in order to understand which of 
them provided the best integration with tools where the final contacts were going to be 
used. Then I developed a written procedure indicating how these databases should be 
handled. 
Once the technical platform was defined, I started to collect contacts. These contacts 
consisted of stakeholders in the clinical research area with potential interest in ARC 
Publishing’s services. For instance, I made a comprehensive search on scientific societies 
holding conferences, so that these contacts can be used for future targeted marketing 
campaigns. These activities contributed to increase my knowledge on the environment in 
which the company operates. 
 
 
2.2. INFORMATION TECHNOLOGIES 
 
Information technologies (IT) play a huge role in today’s world, and at ARC Publishing we 
try to take advantage of the opportunities they provide. In this section I describe the main 
IT-related activities developed during my internship: from testing web-apps to writing IT 
Documentation. 
 
 
2.2.1. Web-app development and testing 
 
From the beginning of my work at ARC Publishing, I accompanied the development of a 
very important IT infrastructure. This process was outsourced to an external IT 
development company and turn out to be extended throughout most of the internship. 
During this process, I tested—along with other company colleagues—the “preview” 
versions of the applications produced, both from the administrator as well as the end-user 
perspective. 
These activities gave me some experience with outsourcing, and particularly with 
outsourcing that does not goes so well. The web-apps under development consisted of a 
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peer-review platform for scientific publications (namely scientific journals) and ARC 
Publishing’s website itself. Given, the complexity involved in these applications, carefully 
prepared requirements were developed when the project was outsourced (before I began 
my internship). Nevertheless, even with very specific requirements laid out, some 
misunderstandings arisen (mainly associated with the applications’ functionally) and 
consecutively delayed the project. By the time of writing of this report the website was 
already accessible online. Appendix 1 provides a screenshot of the final product. 
Accompanying this process allowed me to understand de importance of properly 
monitoring outsourcing activities. In this project, detailed requirements were defined, but 
problems at this level still arisen. This proves how important it is to thoroughly monitor the 
development process to make sure everyone involved is on the same page. 
 
 
2.2.2. Web-app documentation preparation 
 
Highly associated with the development of web-apps is the development of proper 
documentation. Besides testing the web-apps mentioned in the previous section, I also 
developed documentation specially tailored for the system at hand, namely privacy 
policies, terms of use, and user guides. In the following sections I describe noteworthy 
aspects associated with developing each kind of documentation. 
 
 
2.2.2.1. Privacy policies 
Privacy policies assume an ever growing importance. Users are becoming more concerned 
with their digital privacy and even legal requirements are tighter now. To prepare the 
privacy policies for the web-apps previously mention, I had to follow the applicable legal 
requirements, which are now particularly extensive within the European Union. 
Additionally, I had to benchmark privacy policies for similar web-apps in order to 
understand which would be the best approach. Finally, with the requirements and examples 
in mind, I prepared the privacy policies adjusted to the characteristics of the systems. 
With this activity I learned that privacy policies are about being rigorous and honest. 
The policy should be clear, easy to read and understand, and most importantly, it should 
honestly represent how personal data will be handled. Users’ personal data should always 
be respected. But, besides putting in place all reasonably measures to achieve this goal, it is 
crucial to properly inform the users. 
 
 
2.2.2.2. Terms and conditions 
To develop the terms and conditions I followed a process similar to the one described for 
privacy policies: I analysed the requirements, did some benchmark, and then build a 
tailored document.  
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Terms and conditions are the documents in which the company states how the users 
should use the services provided. I understood that it is very important to mention that the 
application must be used for its intended purpose. Associated with these clauses, the 
company also reserves the right to restrict access, and states the conditions in which such 
restrictions apply. The rights of the users are also described. Then some legal clauses are 
usually added to prevent the company from being legally liable from possible damages or 
having the right to compensation in case these damages arise from misuse of the system. 
 
 
2.2.2.3. User guides 
Once the systems were ready, I prepared the user guides that accompany the peer-review 
system. These guides are end-user oriented and so were divided into three different guides: 
the author’s guide, the reviewer’s guide, and the editor’s guide. For each guide I described 
the normal flow of use for the system in a particular user perspective and try to be very 
comprehensive in my approach. 
During this activity I understood that it is not always easy to think of all situations 
possible and place them in these documents. It is crucial to describe every little detail and 
always use the simplest language possible. Is not, however, an easy task easy to place 
ourselves in the end-user position when we already have great experience with the system 
(much less in the naive-user position). Thus, building user guides is always a work in 
progress, these documents will probably need to be updated as new usage issues arise, but 
we should always try to cover the biggest set of situations reasonably possible. 
 
 
2.2.3. Electronic Data Capture software 
 
Electronic data capture software (EDC) is tailored to facilitate the collection of data from 
clinical research. EDC provides gains in efficiency, since it allows the users to enter, 
review, and analyse data in real-time. It also allows gains in data quality since validation 
checks can be easily implemented to identify possible errors at the time of entry. This type 
of software has been increasingly adopted in clinical research. Now, it is widely used in 
large industry-funded clinical trials, but is also starting to be used in other initiatives, such 
academic studies or disease registries [42, 43]. 
In the following sections, I describe the two main activities performed during my 
internship with relation to this kind of software. Initially, I describe the main learning 
outcomes of some “hands-on” experience with open source EDC software. Then, I state 
the main findings from extensive market research on commercial EDC software. 
 
2.2.3.1. Testing “off-the-shelf” open-source solutions 
OpenClinica is one of the most widely known open source EDC solutions. In fact, 
according to OpenClinica’s website: “OpenClinica become one of the world's most widely 
adopted clinical trial software technologies powering research in over 100 countries”. This 
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software is available in two versions: Enterprise edition and Community edition. I tested 
the community edition, which is freely available to download (https://openclinica.com) and 
can be easily deployed. 
To start testing OpenClinica on a “real-life environment”, I had to find a server to 
install the software. After some research on the subject, I came to the conclusion that it 
would be better to install the software on a cloud computing platform (these platforms 
provide users with computing capacity in real-time, without the need for upfront 
investments; hardware is maintained by the provider; the user has access to this computing 
capacity through the internet). So, I set up an Amazon E2C computing instance and after 
some trial and error attempts got the system to function. 
While testing OpenClinica I had the opportunity to understand how very complete this 
EDC software is. I also had to experiment with cloud computing, particularly with Linux 
servers, which proved to be an enjoyable task in the sense that it gave me some insight on 
how these technologies actually work. I also investigated the regulatory requirements 
involved in the use of EDC software for clinical trials conducted with the intent to be 
submitted within a market authorisation application. These requirements are very 
extensive, and although OpenClinica is prepared to support them, the effort required to 
prepare all the documentation needed makes it very difficult to implement a regulatory 
compliant installation of OpenClinica community edition. Thus, several commercial EDC 
solutions are available, with a pre-defined validation package, to facilitate this 
implementation—OpenClinica Enterprise edition being one of those solutions. 
 
 
2.2.3.2. Market research on commercial Electronic Data Capture solutions 
Having in mind the limitations of open source EDC solutions for regulated clinical trials, I 
set out to evaluate the different types of commercial alternatives. This was a very enriching 
activity because it provided me some insights on how the international marketplace 
operates. I had to search the alternatives available and then contact the providers; this gave 
me the chance to practice my English communication skills, mainly because most 
providers contacted me directly by phone. 
In terms of the software itself, I learned how to prepare a set of requirements when 
making this kind of inquiries. I also got a good understanding of the business models 
involved, the types of technological implementation, and the different pricing models used. 
Most importantly, I overviewed the international landscape for this kind of technology, 
which may be of good use for my professional development in the future. 
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2.3. QUALITY ASSURANCE 
 
In today’s competitive world, the quality of work produced assumes an ever growing 
importance. Quality assurance is the designation usually employed to define a whole range 
of activities carried out by organisations to ensure that products or services meet the 
quality requirements. A vital part of these activities is the development of written 
procedures, which ensure tasks are carried out in a pre-defined manner, leading to quality 
and efficient results. Next, I explore the development process for written procedures. 
 
 
2.3.1. Writing Standard Operating Procedures for Information Technology 
activities 
 
The Standard Operating Procedures (SOP) that I develop were related to the handling of IT 
at ARC Publishing. These SOPs were mainly associated with defining the requirements for 
the IT infrastructure as well as requirements for IT users. 
When developing these SOPs I had to think about IT processes that I would not 
otherwise thought of. I identified details in these processes that I would probably not notice 
otherwise. Also, I gained some experience in SOP writing—a vital skill for most 
professionals in this area—particularly in terms of understanding how crucial it is to 
properly define every aspect, but still maintaining the procedure practical and achievable. 
 
 
2.4. EDITORIAL MANAGEMENT 
 
During my internship period, I also accompanied and, in some cases, participated in 
activities associated with the publication of an international peer-reviewed journal. The 
following sections describe these activities. 
 
 
2.4.1. Launching an international peer-reviewed journal 
 
The International Journal of Clinical Neurosciences and Mental Health is an international 
peer-reviewed journal launched by ARC Publishing in April 2013. This is an open access 
journal aimed at providing high-quality publications in the areas of Psychiatry, Mental 
Health, Neurology, Neurosurgery and Medical Psychology. The journal’s editorial board is 
composed by international expert leaders in these medical areas. I had the opportunity of 
accompanying the development of this journal prior to launching and then participating in 
the activities associated with its launching in April 2013. 
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2.4.1.1. Website preparation (review of contents and testing) 
One of my functions in this regard was to prepare the website for launching. I reviewed the 
contents previously prepared and adapted them to the website structure and technical 
capabilities, so that they were the most user-friendly and professional looking possible. 
Appendix 2 provides a screenshot of the final product. 
I also had to deal with implementation problems that arose when the website and peer-
review platform were placed in their final form. Dealing with these issues posed a 
substantial challenge: I did not have the technical capabilities to resolve them, but had to 
expedite their resolution because they the systems’ function and journal’s credibility could 
be potentially impacted. 
Additionally, I also reviewed the journal’s documentation (e.g. authors or reviewers 
instructions). Here, I tried to anticipate potential doubts and make the text the most self-
explanatory possible. In this preparatory phase, I also organised a database of contacts to 
publicise the journal once it was officially launched. 
 
 
2.4.1.2. Call for papers 
To publicise the journal once it was launched, I prepared a general “Call for Papers” email. 
I used the knowledge acquired when working with electronic newsletters to prepare this 
email. In fact, I adapted the format of the newsletter for this purpose and then massively 
send it to the contacts in the journal’s database. 
I tried to make the announcement visually appealing in order to overcome the “direct 
to trash” effect of these kinds of campaigns: users receive various emails with this format 
and visually appealing elements can be very important in gaining their attention for more 
than just a few seconds, and hopefully get them to visit the website to learn more about the 
journal. 
This call for papers was also distributed by other means besides email. A Magazine 
advertisement was derived from the call for papers. This advertisement was published on 
the magazine of the Northern Section of the Portuguese Medical Association, 
“nortemédico”. The advertisement consisted of an entire magazine page with the 
information from the call for papers, and some details on the aims of the journal as well as 
the editorial board. This advertisement is shown in Appendix 3. 
 CHAPTER 3 – MONO-DISCIPLINARY 
ACTIVITIES: MEDICAL WRITING 
 
Medical Writing is about communicating medical science with the right message, to the 
right audience, using the right communication form. Basically, it is about achieving 
maximum communication effectiveness. Although medical writing is an activity thousands 
years old, only in the past century it was established as a clear, separate profession. 
Nowadays, medical writing professionals write high quality pieces in a variety of 
communication/publication forms. Medical writing activities can be broadly categorised as 
follows: 
Regulatory medical writing – producing high quality documentation for regulatory 
purposes. These activities are usually associated with highly regulated areas such as 
research and development of pharmaceuticals and medical devices. This includes the 
production of documentation for clinical trials, but also observational studies or non-
clinical studies. 
Medical communications – producing scientific writing pieces with informational or 
didactic purposes. Medical literature publications (journal articles, books, etc.) are included 
here, but other more teaching-oriented materials are also included, such as slide kits, 
manuals, etc. In broad terms, marketing-oriented medical writing activities may also be 
included in this category, since these marketing campaigns focus on providing scientific 
information with commercial goals [41]. 
Medical writers are employed (of contracted) by a variety of organisations, from the 
pharmaceutical industry, to specialised medical communication agencies. Thus, the range 
of activities performed and outputs produced are increasingly large. Nonetheless, some 
main tasks/outputs can be identified.  
Medical writers have historically been involved in producing regulatory 
documentation associated with development and marketing of pharmaceuticals (e.g. 
clinical trials’ protocols and reports, protocols and reports for non-clinical studies, as well 
as marketing authorisation applications). Writing for the medical literature is also a crucial 
task for medical writers; these activities include the preparation of original research reports 
(for instance, presenting the results of clinical trials to the scientific community), literature 
reviews, book chapters, among others. In a globalised world, in which medical research is 
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often multicentre and multinational, medical writers also translate essential documents to 
facilitate the conduction of research activities or eventually to comply with regulatory 
requirements. Additionally, medical writers may also prepare medical 
information/education materials, such as slide kits and brochures, or participate in 
marketing campaigns, providing scientific writing support [41, 44]. 
Usually associated with medical writing is the concept of medical editing. Medical 
editing can be described as fine-tuning medical writing pieces. These activities can be 
performed by medical writers (some companies adopt this strategy) or by specialised 
medical editors (although such professionals tend to have broader roles, including late-
stage proofreading and publication). Nonetheless, in a broad sense “Medical Writing” 
usually includes both writing and editing. When editing, it is important to check for 
scientific accuracy, grammar, and editorial errors (style inconsistencies, lack of clarity, 
etc.). Editing includes “quality assurance” of documents prepared by a medical writer, but 
also critical revision of documents prepared by other professionals. These activities play a 
crucial role in medical writing, since quality is of essence and only with meticulous review 
we can achieve it [41, 44]. 
One may ask himself if professional medical writing services are so essential when 
authors can simply prepare their documents and then have them reviewed by appropriate 
reviewers/proof-readers. In fact, this question probably goes through the mind of many 
when they first hear of medical writers. Nevertheless, professional medical writing services 
play a crucial—quiet, but crucial—role in today’s medical science and knowledge 
communication [41, 44].  
On the industry front, medical writing is a great asset: regulatory hurdles are tackled 
with tailored, professionally prepared solutions ensuring efficiency and reducing marketing 
introduction times, which may signify great economic added-value. Additionally, 
educational medical writing also presents great added value to the industry since it allows 
prescribers to get to know the industry’s best proposals and solutions. This is particularly 
relevant in today’s crowded market, where prescribers often have difficulties discerning 
the added-value of each alternative [41, 44].  
On the individual investigators front, medical writing consulting also presents 
significant benefits. Medical experts contracting medical writing services often do so 
because to remain experts in their fields they do not have the time or the motivation to 
improve their writing skills and prepare high quality documents. Thus, medical writing 
services portrait as a great tool, since they allow the experts to transmit their insights to 
their peers in an efficient and pleasant manner for both the author (the ideas expressed are 
still the expert’s, is the manner in which they are communicated that is perfected by the 
medical writer) and the reader [41, 44]. 
Medical writers come from a variety of backgrounds. Most have had some experience 
with academic research; many even have PhDs, but at some point decided they wanted to 
get away from the frustrations of “hands-on” research. The common denominator is 
enjoying writing scientific documents and wanting to be able to keep in touch with medical 
science, and perhaps get to know new medical subjects. Independently of their origin, 
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medical writers need to have good organisation and search (through the medical literature) 
skills. They also need to have multidisciplinary knowledge and keep up-to-date on 
applicable regulations and guidelines. Therefore, the medical writer profession constitutes 
a good platform for people aiming at contributing to the development of medical 
knowledge, who prefer working in differentiated but challenging environments on a 
regular basis. 
There are, however, still some controversies about the use of medical writing services 
in the medical literature. Most of which are associated with the so-called “Ghost-writing” 
practices: employing medical writing services to prepare manuscripts without proper 
acknowledgement and sometimes even without proper input from the authors—sometimes 
authors have absolutely no input at all.  
Medical writers associations (e.g. the American Medical Writers Association or the 
European Medical Writers Association) issued strict guidelines for ethical conduct in 
medical writing. These guidelines generally agree in considering that listed authors should 
have significantly contributed to the analysis and interpretation of results and feel 
comfortable taking responsibility for the contents of the publication. Thus, for most 
research articles, medical writers do not qualify as authors. Nevertheless, guidelines also 
mention that in these circumstances medical writers should be properly acknowledged, 
with their role and source of funding specified [45, 46].  
In this chapter, I describe the main activities performed as a Medical Writer at ARC 
Publishing. Since this is my area of specialisation, a major proportion of the internship 
period was spent on these activities. My tasks fall mainly within the “Medical 
Communications” field previously described. They range from writing original research 
reports to accompanying the translation of clinical research documents, to editing books, 
and to editing other diverse scientific documentation. 
 
 
3.1. MANUSCRIPT WRITING (ORIGINAL RESEARCH REPORT) 
 
Preparing an original research report was one of the most challenging tasks I had the 
opportunity to undertake during this internship. This was a manuscript for publication on a 
highly regarded peer-reviewed journal. The manuscript was jointly prepared by me and 
another ARC Publishing associate. It combined data from three different clinical trials on 
bipolar disease treatment. Data was already analysed: our job was to present the findings in 
a scientific manuscript, using the clinical trial reports as a starting point. 
First, we analysed the clinical trial reports and prepared an outline for the manuscript. 
This allowed us to make sure the writing was aligned with the clients’ intents. Then we 
went back to the reports and studied them in great detail to capture all important findings 
and understand which would be the best presentation form.  
At this point, we started to define which figures and tables would be presented. 
Constructing these tables and figures revealed to be a quite challenging task, because the 
clinical trial reports did not always presented information in the clearest way. Here, the 
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situation was aggravated by the fact that the reports for the three studies had been prepared 
by different organisations, and thus the presentation forms were slightly different. 
Nonetheless, after some effort putting these tables and figures together, we were able to 
capture the main findings for the three studies. 
Afterwards, we began writing the text around the data presentations. I found the 
“Methods” section relatively easy to write because the methods employed were already 
very well defined in the clinical trial protocol and clinical trial report. The results section 
was not so straightforward because it had to complement the tables and figures. We 
pointed out the main findings, exposing what the data in the tables and figures meant 
without actually repeating these data.  
To write the introduction I conducted a literature search, to make sure relevant recent 
publications were mentioned as needed. I found this activity particularly enriching because 
it gave me additional knowledge on the subject at hand. As to the “Discussion” section it 
was important to make sure the authors’ views were properly represented, but it was also 
important to be cautious about all the claims made—once something is written it can be 
taken back!  
Finally, we wrote the abstract, based on the whole manuscript. Here, good 
summarising skills were crucial to portrait the best picture of the manuscript in a very 
limited space. Nevertheless, I found that as I worked on the whole document, summarising 
the main points came relatively naturally, with exception from some sentences, of course. 
This was a very important assignment in developing my medical writing skills. It gave 
me experience with two types of medical writing: regulatory writing, in the form of clinical 
trial protocols and clinical trial reports; and medical communications, in the form of peer-
reviewed journal publications. Besides, giving me experience with this two, perhaps most 
crucial, areas in all medical writing, this assignment was also pleasant to develop since it 
required a comprehensive, rigorous, and methodological approach. 
 
 
3.2. TRANSLATION OF CLINICAL DOCUMENTS 
 
During the internship, I also participated in the process of translating clinical 
documentation. The clinical study protocol, the informed consent form, and the case report 
forms were included. The documents were originally in Spanish and were translated into 
Portuguese. My task was editing the Portuguese translation. 
This task provided me experience with clinical study documentation (whereas the 
previous task encompassed clinical trial documentation). Besides, I had the chance to 
understand some particularities of Spanish-Portuguese translations. I also improved my 
editing and proofreading capacities, which is are crucial skills for medical writers. 
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3.3. BOOK EDITING 
 
Book editing activities encompassed two books: one very preliminary book in need for 
major content revisions, and one late-stage book ready for proof-reading, production, and 
print. Thus, working with either one of these provided me quite different experiences and 
learning outcomes. 
The first book—the preliminary one—was about special topics in therapeutics. Here, 
the chapters were prepared by authors without much writing experience. Despite some 
chapters being reasonably good, most needed substantial editing (and even content 
revision). Since this assignment took a fair among of time to conclude, it was central in 
improving my writing and editing skills. I learn to spot bad writing signals. I acquired the 
capacity to better suggest alternative forms of writing. And, I even built somewhat 
predefined mental schemes for implementing corrections. Here, I also learned that editing 
can be tough since the editor cannot change meaning without the authors’ consent. 
Moreover, I recognised the value of my multidisciplinary academic training: in technically 
understanding what I was reading, I was able to come up with better editing solutions. 
As for the second book—the late stage one—it addressed health informatics issues. 
Since, this book was already in an advanced stage when I first started working on it, here I 
learned about the final stages of book production and publishing. I learned how to use 
specialised software (Adobe InDesign) and absorbed particular aspects of book publishing 
previously unknown to me. This assignment was particularly interesting because I was 
constantly learning as I was going through the production process. 
 
 
3.4. REVISION AND QUALITY CONTROL OF SCIENTIFIC 
DOCUMENTS 
 
During this internship I also had the chance to review different types of scientific 
documentation. I gained knowledge on the contents of those types of documents, most of 
which I had some previous knowledge at the macro-structure level from my academic 
training. Here, I built upon that knowledge and gained new insights on scientific 
documentation to produce those documents, which may prove to be very important for my 
career development. 
More importantly, I improved my editing skills. I saw good writing examples. I 
improved my capacity to critically review writing pieces. And, I learned new ways for 
streamlining writing. With time I began to incorporate these insights in my writing and 
editing on a daily basis. Next, I will probably start using these approaches without even 
thinking about them. 
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3.5. LESSONS LEARNED AS A MEDICAL WRITER 
 
If had to identify the most important lesson from my medical writing activities, I would 
probably say that it was the understanding that in medical writing simplicity is key. By 
simplicity I mean presenting the same complexity of thought in the clearest and straightest 
way possible. Not reducing the scientific accuracy or the deepness of the ideas transmitted, 
just making the text flow better and be enjoyable to read. Before, I often tried to make text 
overly complicated. I thought it better reflected my good writing skills. Now, I understand 
text should be simple, well-crafted, and lively. This way, readers actually enjoy the pieces, 
and thus are much more likely to keep reading. 
I also understood that to prepare scientific documents, one should also be rigorous. All 
calculations should be performed with caution, and then double-checked. Spelling is, of 
course, of the outmost importance in professional writing. Professional writers have the 
obligation of identifying misspellings—after all that is what proof-reading is for. Other 
than these technical glitches, the ideas transmitted in the text must also be well-thought of. 
All statements should be carefully considered and clear enough so that alternative 
interpretations don’t arise.   
Before I start this training as a medical writer I was already a big fan of planning, but 
now I appreciate even more these activities. Planning not only improves efficiency, but 
also ensures alignment—very important between writers and editors on the same project, 
but, perhaps even more vital between the writing staff and the client. Planning involves 
preparation of outlines, determining the roles of each staff member, and of course, 
scheduling. During my internship I learned how to perfect the use of these tools, which 
allowed me to improve my work efficiency and increase my self-fulfilment as I was seeing 
my tasks performed at an ever-growing pace. 
Finally, I also learned that, perhaps contrary to common belief, good writing skills can 
actually be learned and trained. For medical writing in particular, training and experience 
play essential roles. Medical writers have to learn the specificities about every document 
they produce, have to understand their audiences, and have to do so in record times. 
Therefore, while medical writers should have some degree of natural writing talent, they 
should also work hard to improve their scientific communication skills on a daily basis. 
 
 CHAPTER 4 - DISCUSSION AND CONCLUSIONS 
 
During this curricular training period, I had the opportunity to develop an array of 
diversified tasks. As planned, my efforts were divided between medical writing-related 
activities and other varied activities.  
Developing this set of tasks provided me a complete training experience. While I 
greatly improved my specialised skills in medical writing, I also improved my 
multidisciplinary capacity. This training model proved to be a great asset for someone just 
starting after several years of academic education. 
In the following sections, I discuss how these curricular training activities contributed 
to my learning experience and impacted my skill’s set. I start by discussing my experience 
with multidisciplinary activities. Then, I go through the medical writing activities. Finally, 
I conclude on the overall learning experience and its implications to my future career 
development. 
 
 
4.1. MULTIDISCIPLINARY ACTIVITY 
 
Multidisciplinary activity provided me a wide work experience during this internship. With 
these undertakings, I got to know new working environments, develop new working 
routines, and got better understandings of the “real marketplace”. Besides, when 
undertaking multidisciplinary tasks, I also learned about potentially interesting new topics, 
such as medical publishing. 
These activities also contributed to widen my spectrum of professional competences. 
In terms of web-app development, I understood how important it is to define the right set 
of requirements—detailed as reasonably possible, and then even more detailed! I 
acknowledge how crucial it is to tailor website’s contents to deliver the right message to 
the right audience. And finally, I also incorporated new technical concepts on information 
technologies and even got some experience with IT administration. 
Also, I got a better perception of the clinical data management fields. I learned about 
the different types of EDC alternatives (open source vs. commercial) and the different 
types of EDC needs (i.e. different types of studies require different types of technical 
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capabilities). I also approached regulated clinical data management and learned about 
specific EDC solutions while inquiring providers. 
Finally, I also learned about the promising new opportunities in medical publishing. 
Working on the development and launching of a new international medical journal 
provided me a deep understanding of these fields of activity. Besides, I also learn about the 
increasing trend in Open Access publishing and the opportunities it poses. Working with 
book publishing was also very rewarding, since I approached processes that I would not 
otherwise thought about, but which are very interesting. 
Thus, I look forward to continue developing work in these areas. I have always had 
particular interest in IT-related subjects, therefore carrying out IT tasks constituted an 
enjoyable experience. With the medical publishing fields I was not so familiar, nonetheless 
discovering the opportunities medical publishing presents was particularly gratifying, and 
thus I intend to keep exploring this area. 
 
 
4.2. MEDICAL WRITING EXPERIENCE 
 
My medical writing experience, as I was expecting from the beginning, was very pleasing 
and fulfilling. This was an area of great interest to me since I first heard of it. Working in 
medical writing allows people to keep in touch in full-blown science without actually 
having to deal with many of the disappointments and frustrations associated with it. I find 
this notion particularly interesting for developing a career, in opposition to the instability 
and ever-changing environment associated with other scientific activities. 
During this internship, I greatly developed my medical writing skills. I started using 
new tools: from computer applications to medical dictionaries. I improved my planning 
capacities before start writing. I worked with different types of documents, and understood 
important differences in the preparation of each type. And lastly, I improved my overall 
writing skills: using new vocabulary, proactively alternating punctuation, applying 
adequate structural forms, developing visual aids, simplifying texts, and tailoring messages 
and contents. 
In the future, I look forward to also keep developing medical writing activities. One 
thing I learn during this training period was that a medical writer is continuously learning. 
In my case, a beginner in these fields, I still have much to learn. Medical writing is a broad 
field, with many little details that only with continued experience are uncovered. This 
continued activity will also give me chance to understand which areas I enjoy the most, so 
that then I can try them as a specialisation. 
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4.3. OVERALL LEARNING EXPERIENCE 
 
Activities developed at ARC Publishing were a great complement to my academic training. 
Although my academic training was already oriented to the practical application of the 
knowledge I was acquiring, here I had the chance to understand how the actual 
marketplace looks like. 
The bachelors (in Biomedical Sciences) and masters (in Pharmaceutical Biomedicine) 
degrees provided me with very good visions of medical science, with particular emphasis 
on pharmaceutical medicine and clinical research. Here, I went even further and got to 
know an even more specialised area: medical communication and publishing. This 
specialisation was very much facilitated by my broad academic background, since I 
already had some degree of knowledge on most subjects I worked on. This asset was 
particularly noticeable when carrying out my medical writing functions, because my 
medical science background allowed me to get very good understandings of what I was 
writing about. 
Additionally, this internship provided me the opportunity to learn about issues not 
usually addressed in most courses—if any. I worked in new fields of medical publishing, 
such as Open Access publishing. I even accompanied some business development 
activities. Thus, this multifaceted experience was also a great complement to the academic 
education because it better prepared me to join the working marketplace. 
During this training period I have also encountered some difficulties. I had to enhance 
my interpersonal communication skills, which due to my quiet style were not always the 
most desirable. I also faced some hurdles during the IT development tasks. Here, the 
difficulties (and their resolution) were not controlled by me, but I still had to make 
considerable efforts to expedite their resolution. To develop some tasks that I was not so 
familiarised with, I also had to conduct some research, but on a general manner I was able 
to overcome the difficulties. 
This internship period also represented added-value for ARC Publishing. Some of the 
activities I executed during this period included large components of research, and thus 
contributed to expand the company’s body of knowledge. Other activities were directly 
related to the commercial activity of the company. For example, I had an active role in 
preparing and launching the company’s website, launching the International Journal of 
Clinical Neurosciences and Mental Health, and conducting medical writing work. 
Additionally, some of my undertakings laid the foundations for future business 
development in areas not yet explored by the company. These activities are of particular 
importance, since at a start-up company refinement in the existent processes and 
development of new business areas might be key factors for success.   
The objectives laid out for these 9 months of training (and outlined in Chapter 1) were 
largely accomplished. I got the chance to apply the knowledge I acquired during my 
academic education. Both my general training on biomedical sciences as well as my views 
on pharmaceutical medicine constituted a great asset and were very important in 
successfully conducting the assigned tasks. This training also provided me a better insight 
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of the marketplace in the fields of medical research and communication. I got a better 
understanding on the business opportunities available, I overviewed the business processes 
involved, and learn about new areas of interest.    
The wide range of activities I worked on helped me improve my general work 
capability, since I had little previous work experience. The activities defined here as 
“Multidisciplinary” had a crucial role in attaining this objective. As for the medical writing 
experience, I learned on a daily basis, complementing my previous medical writing 
notions, and achieving a fairly high level of expertise (taking into consideration, of course, 
my limited experience).  
Hence, this curricular internship provided me a solid experience, complementing my 
previous knowledge and introducing me to the working environment. Additionally, it also 
widened my perspectives for future career development. 
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Appendix 1. Screenshot of ARC Publishing's website on May 2013 
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Appendix 2. Screenshot of the International Journal of Clinical 
Neurosciences and Mental Health website upon launching 
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Appendix 3. Advertisement published on the magazine of the Northern 
Section of the Portuguese Medical Association, “nortemédico”. 
 
